Home

Patrick Fisher

CIK 1677842 · President, Global Limb Recon · last filed 2026-09-03

Patrick Fisher is a President, Global Limb Recon who has filed 38 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing shows the insider sold $1.4K of OFIX on Sep 3, 2026. Across all open-market trades the lifetime net is −$786.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $487.7K across reported positions. 31 SEC filings were submitted jointly with Wright Medical Group N.V.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$487.7K

Companies

4

Total Filings

38

Lifetime Open-Market Net

-$786.9K

Filer Profile

Reported Address
1023 CHERRY ROAD
MEMPHIS, TN 38117
Related Filers
Wright Medical Group N.V. — 31 joint filings, latest 2020-11-13
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
OFIX President, Global Limb Recon 51,069 $9.55 $487.7K -$62.4K 7 2026-09-03
Wright Medical Group N.V. (WMGI) Delisted President, Lower Extremities 51,537 — — -$221.8K 7 2020-08-19
Wright Medical Group N.V. (WMGIZ) Delisted President, Lower Extremities 33,064 — — -$377.7K 19 2018-12-17
Wright Medical Group N.V. (WMGI.Z) Delisted President of Lower Extremities 38,736 — — -$125.0K 3 2016-08-24

Recent Filings

38 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-09-03 OFIX Sell (S) −150 -$1.4K EDGAR
2026-09-01 OFIX Notice (144) −450 -$4.2K EDGAR
2026-08-20 OFIX Sell (S) −1,295 -$13.1K EDGAR
2026-03-06 OFIX Sell (S) −1,536 -$19.6K EDGAR
2026-03-05 OFIX Grant (A) +21,105 $0 EDGAR
2025-08-20 OFIX Sell (S) −1,996 -$28.4K EDGAR
2025-03-05 OFIX Grant (A) +14,723 $0 EDGAR
2024-08-19 OFIX Grant (A) +15,319 $250.0K EDGAR
2020-11-13 — Mixed −51,537 -$1.79M
2020-08-19 Wright Medical Group N.V. (WMGI) Delisted Sell (S) −1,261 -$38.0K EDGAR
Showing 1–10 of 38
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.